VSJ Fincap’s Post

At Forum Ventures, we understand the pivotal role innovation plays in advancing the healthcare industry amid financial strains and staff shortages. That's why, under the guidance of Michael Cardamone and Naomi Goez, we engaged with top executives from Mayo Clinic Ventures, Hackensack Meridian Health, Cone Health Ventures, and University Hospitals Ventures. Our objective? To unravel the complexities of the healthcare system and forge a path forward for healthtech startups. Our latest report offers a comprehensive exploration, shedding light on how over 6,000 U.S. hospitals are navigating their biggest challenges. From operational efficiencies to advancing remote and hybrid care models, the insights provided focus on areas critical for improving patient outcomes. Mike commented, "We believe technology has the power to transform healthcare globally. Our goal is to arm healthtech startups with the necessary insights to navigate this complex industry, establish product-market fit, and drive significant improvements." 📥 Download the report to dive into these insights and more: https://lnkd.in/eKtEpTpn Thanks to our experts Shai Ran Sapir, Sandra Powell-Elliott, David Heenan, and Matthew Zenker for their contributions. 🔍 Also explore our digital early stage health tech market map, live, searchable, and filterable here. https://lnkd.in/eptg9A68 Founders, submit your company to be featured! #healthcare #innovation #healthtech #earlystage #healthtechfounders

Really interesting and thorough report by Forum Ventures on innovation in healthcare. It's also very nice to see Toothly AI on Forum's Early Stage Healthcare Market Map next to some other incredible companies. It's definitely worth the read! #dentalai #oralhealth #mit #forumventures #digitalhealth #healthtech #toothlyai

While Forum Ventures invests in early-stage B2B SaaS startups across every vertical, we are particularly interested in a few markets and are developing our investment theses around each of them: healthcare, vertical AI, fintech, AI agents, supply chain, to name a few. Today we released our first thesis-specific report on the U.S. healthcare market! This report is a consolidation of conversations our team had with innovation executives at four of the top healthcare systems in North America. Healthcare founders – you can’t get this inside scoop anywhere else. If you want to ensure you’re solving the right problems in this space, you have to read this. https://lnkd.in/ggEkz46N More about the report, conversations and contributors below 👇 Also, check out our latest digital healthtech market map. Founders - submit your company to be featured! https://lnkd.in/gEBRnktu #healthcare #innovation #healthtech #earlystage #healthtechfounders

It's no secret that our health systems need improvement. 📑 Our latest report Forum Ventures dives into how over 6,000 U.S. hospitals are navigating their toughest obstacles, from enhancing operational efficiencies to advancing remote and hybrid care models. These insights are crucial for any startup aiming to improve patient outcomes and achieve significant growth. We are super excited to have worked with partners like the Mayo Clinic Ventures, Hackensack Meridian Health, Cone Health Ventures, and University Hospitals Ventures. To deeply understand the complexities of the healthcare system and create opportunities for Healthtech startups to thrive. We already have amazing companies tackling some of the most critical problems in Health and are looking to make even more investments in the space. If you are a founder just getting started building in health care DM me. I'd love to chat. 📥 Download the full report (Link in the comments)

To end the week on a more positive note PitchBook recently published a list of digital health companies that are likely to IPO this year. During the Covid19 induced mad valuation hype several digital health companies went public, but this ended badly for many of them (Babylon Health, Pear Therapeutics, Better Therapeutics and now Akili). Allowing early investors in digital health companies to gain liquidity via a listing on the capital markets helps the sector grow by allowing capital to be recycled in the space and by providing a pathway for investors to cash out of their investment. I would argue that several of the initial batch of digital health companies that went public were not in suitable shape to do so. Most had little to no revenues, promised massive growth that was never delivered and none of them were profitable. The current batch of IPO contenders includes companies that can be considered digital therapeutics companies (Noom & Hinge). Several also have businesses that reply on telemedicine to enable their service delivery (Noom, Ro, Lyra and Hinge) but do not rely on telemedicine as the core differentiator of their business model. Many of these companies also have built sizable revenue bases showing they can scale their commercial models (noting that I didn't say 'scale profitably'!). The big question on my mind is will the companies that raised capital at high valuations several years ago be able to hold onto these valuations when going public. Based on the info provided by Pitchbook it's estimate that Hinge, Ro and Lyra last raised capital in the $6 billon valuation range. Sense checking this; Hinge's revenues are estimated to be around $300mil, so their current valuation would price them at around 20x revenue which is high. At the end of the day the sector would benefit from a couple of digital health companies being successful when going public, and hopefully the next batch of companies taking this route become the success stories we need. #digitalhealth #digitaltherapeutics #digitalhealthcare

Ever tried to revolutionize healthcare and felt like you're climbing Everest? The #healthtech #startup ecosystem is a dynamic beast. It’s not just about having cutting-edge technology; it’s about understanding patient needs, navigating regulatory landscapes, and building trust with healthcare professionals. The journey from an innovative idea to a tangible impact on patient care is thrilling but fraught with challenges. My advice? Focus on small wins. Validate early and often. Engage directly with your end-users—patients, doctors, nurses—to refine your product iteratively. Remember, in healthtech, #empathy isn't just a buzzword; it's the foundation of innovation. What hurdles have you faced in launching your healthtech venture? How did you overcome them? Share your thoughts!

Over the past decade, the lack of quantitative insight into what defines ‘typical’ or ‘best in class’ in building and scaling tech-enabled care organizations has been a significant gap. To fill this gap, the Bessemer Venture Partners Healthcare team annually publishes the “State of Health Tech” report where they analyze 50 leading healthcare businesses, uncovering fundamental trends and benchmarks that are crucial for CareOps leaders to succeed. Building on the success of last year’s panel, CareOps will host Sofia Guerra to dig deeper into their research and answer questions such as: 1️⃣ What are important leading and lagging indicators of performance of tech-enabled clinical delivery? and how do these vary for company stage and clinical model? 2️⃣ What key performance indicators (KPIs) should I focus on to drive efficient growth, and prove both the financial and clinical robustness and scalability of my clinical model? 3️⃣ Considering the recent market corrections, what strategies should new health tech startups adopt to attract investment and achieve sustainable growth? If you want to uncover the key benchmarks driving healthtech today, you can register here: https://lnkd.in/dazwJTg3 P.S. There is a high chance that this session will not be recorded so make sure you join us live.

This is optimal.

🚨Investment Announcement: We're thrilled to announce our latest investment in BrainCapture, a Danish healthtech startup on a mission to revolutionize neurological diagnostics in emerging markets. With over 4 billion people lacking consistent and affordable access to these critical services, BrainCapture is tackling this global challenge head-on. By leveraging the power of modern technologies like smartphones, connectivity, AI, and automation, BrainCapture is developing a portable, telemedicine-optimized EEG device that can bring much-needed diagnostic services to underserved regions worldwide. Their innovative approach to democratizing EEG has already shown promise through successful trials and usability tests in Africa and Asia. 🧠 Learn more about BrainCapture: https://lnkd.in/dbQeF7YS Welcome, Tue Lehn-Schiøler, Paul Loomis, and Radu Gătej, to the Verge community! We're excited to support BrainCapture push the boundaries of brain diagnostics to the next level and make a lasting impact on global health. 🚀 #HealthTech #ImpactInvesting #Neurology #Innovation #EEG #Epilepsy #MedTech #BrainHealth

In this episode from the DHI archives, co-host Carrie Nixon talks to startup veteran and Director of TMC Innovations, Thomas Luby, PhD., and Emily Reiser PhD, Associate Director of Innovation, about how the largest medical center in the world looks at the innovation ecosystem and the future of healthcare. In this episode you’ll discover: ➡️ What the ecosystem of innovation looks like at TMC Innovations; ➡️ How TMC Innovations helps startups via accelerators, resources, and their venture fund; ➡️ How they’ve seen health system partners work with digital health companies; ➡️ How specific digital health startups are adapting and thriving during the pandemic; and ➡️ What they think is the most pressing need in healthcare in the next 3 years. Listen here: https://lnkd.in/gTziPJVY